First subject received unilateral administration of NRTX-1001 in a new non-MTS cohort; no significant surgical complications ...

Temporal lobe epilepsy (TLE) is a common form of epilepsy characterized by recurrent seizures originating from the temporal lobe of the brain. One of the less common causes of TLE is the presence of ...

In a retrospective cohort, a clinical heuristic composed of eight binary variables helped identify which patients with medial temporal lobe epilepsy (MTLE) were best suited for stereotactic laser ...

Seizures can be predicted more than 30 minutes before onset in patients with temporal lobe epilepsy, opening the door to a therapy using electrodes that could be activated to prevent seizures from ...

Please provide your email address to receive an email when new articles are posted on . Surgery for mesial temporal lobe epilepsy correlated with a reduction in imaging-defined brain age, indicating ...

Epilepsy affects approximately 1-in-26 people and the most common form, known as temporal lobe epilepsy (TLE), often cannot be adequately treated with anti-seizure medications. Patients with this form ...

New research by the Human Brain Project has found that in the brains of patients with epilepsy, changes in large scale neuronal activations can be detected in the brain's resting state activity, even ...

A research team from Beijing Tiantan Hospital has conducted the largest clinical investigation to date into the use of ...

Temporal lobe epilepsy (TLE) is one of the most common types of epilepsy worldwide. Although symptomatic medications are available, one-third of TLE patients remain unresponsive to current treatment, ...

A novel drug candidate to treat temporal lobe epilepsy (TLE) has been identified, which suppresses TLE-induced neuroinflammation and curbs seizures. TLE is one of the most common types of epilepsy.